Share this article
Go deeper with GlobalData
Related Company Profiles
Sign up for our daily news round-up!
Give your business an edge with our leading industry insights.
CN Bio licenced a Hepatitis B drug discovery programme from Bristol-Myers Squibb and Astellas Pharma agreed to acquire Belgium’s Ogeda for €800m. Pharmaceutical-technology.com wraps up the key headlines from April.
May 1, 2017